Core Insights - The event "Entering the Legendary Secretary of the Board and the Launch of the Book 'Legendary Secretary of the Board'" was successfully held in Suzhou, attended by prominent figures from the Chinese listed companies and the publishing industry [1] - The book 'Legendary Secretary of the Board' features real cases from 38 exemplary individuals, showcasing the innovative spirit and compliance standards of the secretary profession, emphasizing its potential as a lifelong career [2] - Legendary secretaries have played a crucial role in the evolution of corporate governance in China, contributing to significant reforms and innovations in the capital market [3] Group 1 - The event was co-hosted by Guotai Junan Securities, Board Magazine, and Value Online, with over 20 executives from listed companies in attendance [1] - The book aims to provide a foundational logic for the new generation involved in corporate governance, promoting a spirit of innovation within regulatory frameworks [2] - The contributions of legendary secretaries have been pivotal in navigating challenges in the capital market, including the promotion of governance systems and the resolution of early governance crises [2][3] Group 2 - Notable figures such as Hu Zhi Kui and Luo Shou Sheng are highlighted for their innovative practices that have significantly impacted the capital market [3] - The event included discussions on key career milestones for secretaries, new thinking in mergers and acquisitions, and future planning for young professionals [3] - The book serves as a historical narrative of the evolution of Chinese listed companies, illustrating the transition from exploration to leading reforms [3]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

北京城建投资发展股份有限公司 2025 年第一次临时股东会资料 四、股东及股东代表发言时，应首先进行自我介绍。为了保证股东会的高效 率，每位股东及股东代表发言应简洁明了，发言内容应围绕本次股东会的主要议 题，每位股东及股东代表发言时间不超过 5 分钟。股东会主持人可以指定相关人 员代为回答，相关人员在回答问题时也不超过 5 分钟。股东会主持人可以拒绝回 答与会议内容或与公司无关的问题。 五、为保证股东会顺利进行，全部股东发言及相关人员回答问题时间控制在 30 分钟以内。董事会欢迎公司股东以各种形式提出宝贵意见。 2025 年 7 月 2 日 北京城建投资发展股份有限公司 2025 年第一次临时股东会会议须知 为维护投资者的合法权益，确保公司本次股东会的顺利召开，根据《公司 章程》和《股东会议事规则》的有关规定，现将本次会议注意事项宣布如下： 一、本次股东会设秘书处，具体负责会议有关程序方面的事宜。 二、股东会期间，全体出席人员应以维护股东的合法权益、确保股东会正常 秩序和议事效率为原则，认真履行法定职责。 三、出席股东会的股东及股东代表依法享有发言权、质询权、表决权等权利。 股东及股东代表要求发言时，应在股东 ...

证券代码：600266 证券简称：城建发展 公告编号：2025－35 北京城建投资发展股份有限公司 关于收到华能资本服务有限公司现金分红的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 华能资本服务有限公司（以下简称"华能资本"）注册资本 98 亿元，北京城建投资发展股份有限公司（以下简称"公司"）持有 2.8 亿元，占其注册资本的 2.86%。根据华能资本 2024 年度利润分配方 案，公司收到 2024 年度第一次分红款 23,625,000.00 元。该笔款项将 计入公司 2025 年度投资收益。 特此公告。 北京城建投资发展股份有限公司董事会 2025 年 7 月 2 日 ...

Meeting Details - The first extraordinary general meeting of shareholders for 2025 is scheduled for July 16, 2025, at 14:30 [1] - The meeting will be held at the 9th floor conference room of Beijing Urban Construction Development Building, located at No. 11, Beitu City West Road, Chaoyang District, Beijing [1] - Voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's online voting system [1] Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's online voting system, with voting available from 9:15 to 15:00 on the day of the meeting [1][2] - Shareholders holding multiple accounts can aggregate their voting rights across all accounts for the same category of shares [2][3] - Votes cast through different methods for the same resolution will be counted based on the first vote submitted [5] Meeting Agenda - The meeting will review proposals that have already been approved by the company's board of directors [2] - There are no related shareholders required to abstain from voting on the proposals [2] Attendance Requirements - Shareholders registered by the close of trading on July 9, 2025, are eligible to attend the meeting [4] - Legal representatives and other appointed individuals can also attend the meeting [4] Proxy Voting - Shareholders can appoint proxies to attend and vote on their behalf, with specific instructions required on the proxy form [5][6] - The voting rights for each shareholder are determined by the number of shares held as of the registration date [6]

证券代码：600266 证券简称：城建发展 公告编号：2025-32 北京城建投资发展股份有限公司 关于董事长离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 二、离任对公司的影响 2 1 姓名 离任职务 离任时间 原定任期 到期日 离任原因 是否继续在上 市公司及其控 股子公司任职 是否存在 未履行完 毕的公开 承诺 储昭武 董事、董事长、 战略发展与投 资决策委员会 委员、预算委 员会委员及提 名与薪酬委员 会委员 2025 年 6 月 30 日 2027 年 7 月 24 日 退休 否 否 一、董事提前离任的基本情况 公司董事会对储昭武先生在任职期间为公司发展所做出的贡 献表示衷心感谢！ 特此公告。 北京城建投资发展股份有限公司董事会 2025 年 7 月 1 日 储昭武先生因退休原因，不再担任公司任何职务，储昭武先 生的离任不会导致公司董事会成员低于法定人数，不会影响公司 董事会正常运作。储昭武先生将按照公司规定做好交接工作。 ...

证券代码：600266 证券简称：城建发展 公告编号：2025-33 特此公告。 北京城建投资发展股份有限公司董事会 本公司董事会及全体董事保证本公告内容不存在任何虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性 和完整性承担法律责任。 2025 年 6 月 30 日，北京城建投资发展股份有限公司（以下 简称"公司"）召开第九届董事会第二十次会议，审议通过了《关 于储昭武先生不再担任公司董事、董事长及专门委员会委员的议 案》、《关于推举邹哲先生代行董事长、法定代表人职责的议案》。 储昭武先生因退休原因，不再担任公司董事长等职务，具体内容 详见公司发布的 2025-32 号公告。根据《公司法》、《公司章程》 规定，为保证公司正常运作，与会董事共同推举邹哲先生代为履 行董事长、法定代表人职责，期限至选举出新任董事长止。 2025 年 7 月 1 日 北京城建投资发展股份有限公司 1 关于邹哲先生代为履行董事长、法定代表人职责的公告 ...

北京城建投资发展股份有限公司 关于召开2025年第一次临时股东会的通知 证券代码：600266 证券简称：城建发展 公告编号：2025-34 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2025年第一次临时股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 7 月 16 日 14 点 30 分 召开地点：北京市朝阳区北土城西路 11 号城建开发大厦九楼会议室 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年7月16日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 7 月 16 日 至2025 年 7 月 16 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 ...

证券代码：600266 证券简称：城建发展 公告编号：2025-31 北京城建投资发展股份有限公司 第九届董事会第二十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 2025 年 6 月 30 日，北京城建投资发展股份有限公司（以下简称 "公司"）第九届董事会第二十次会议在公司六楼会议室召开，会议 通知和材料已于 2025 年 6 月 27 日通过书面及电子通讯方式送达全体 董事。本次会议应参会董事 7 人，实际参会董事 6 人，董事长储昭武 因个人原因未能亲自出席会议，委托董事邹哲代为出席并表决。与会 董事共同推举董事邹哲为会议主持人，公司部分高级管理人员列席了 会议。本次会议的召开符合《公司法》等有关法律法规和《公司章程》 规定。 二、董事会会议审议情况 本次会议审议通过了以下议案： （一）关于储昭武先生不再担任公司董事、董事长及专门委员会 委员的议案 因退休原因，储昭武先生不再担任公司董事、董事长、战略发展 1 与投资决策委员会委员、预算委员会委员及提名与薪酬委员会委员职 务。董事 ...

Investment Rating - The report maintains a "Positive" rating for the real estate and property management sectors [4][31]. Core Insights - The real estate market is showing signs of recovery with a week-on-week increase in both new and second-hand property transactions, indicating a potential stabilization in the market [4][31]. - The report emphasizes the need for continued policy support to enhance market conditions, particularly in light of the ongoing inventory reduction trends [4][31]. Industry Data Summary New Housing Transactions - In the week of June 21-27, 2025, 34 key cities recorded a total new housing transaction volume of 3.792 million square meters, representing a week-on-week increase of 51.1% [5][8]. - Year-on-year, new housing transactions in June decreased by 13%, with first and second-tier cities seeing a decline of 11% and third and fourth-tier cities experiencing a 26% drop [8][9]. Second-Hand Housing Transactions - For the same week, second-hand housing transactions in 13 cities remained stable with a slight increase of 0.5%, while the cumulative transaction volume for June showed a year-on-year decrease of 5% [13][22]. Inventory and Supply - In the week of June 21-27, 2025, 15 cities launched 1.82 million square meters of new housing, with a sales-to-launch ratio of 0.85, indicating ongoing inventory management challenges [22][31]. - The total available housing inventory in these cities was 89.79 million square meters, reflecting a week-on-week increase of 0.3% [22][31]. Policy and News Tracking - The report highlights key policy developments aimed at stabilizing the real estate market, including measures to support first-time homebuyers and families with multiple children [31][34]. - Recent statements from government officials indicate a commitment to expanding domestic demand and enhancing consumer confidence in the real estate sector [31][34].